Skip to Content

Find Comparable ETFs for iShares U.S. Healthcare ETF

iShares U.S. Healthcare ETF

IYH - PCX
ETF Category
Health & Biotech Equities
Asset Class
Equity
AUM
$3,373M
Expense Ratio
0.39% (Low)
Trading Volume
113.0K (Moderate)
Issuer
BlackRock, Inc.
Number of Holdings
109
Inception Date
2000-06-12 (24 years)
Momentum
Very Weak Neutral Very Strong
AUM
Micro Medium Very Large
Concentration
Very Low Very Low Very High
Volatility
Very Low Low Very High
Overview
Momentum
Concentration
ESG
P/E Ratio
21.73
Annual Dividend Rate
2.58%
Beta
0.71
50-Day Moving Average
$60.69
Price vs. 50-Day MA
2.60%
200-Day Moving Average
$62.22
Price vs. 200-Day MA
0.08%
1 Year Fund Flow
-$171M (-5% of AUM)
3 Year Fund Flow
$244M (7% of AUM)
5 Year Fund Flow
$88M (3% of AUM)
% in Top 10 Holdings (Market Cap Weighted)
55.80%
% in Top 15 Holdings (Market Cap Weighted)
67.05%
% in Top 50 Holdings (Market Cap Weighted)
92.52%
ESG Score
6.6400
ESG Peer %
58.08
ESG Global %
54.28
Carbon Intensity (Tons CO2e/$M Sales)
14
ESG Exclusion %
0.00
Sustainable Impact %
11.09

Vanguard Health Care Index Fund ETF Shares

VHT - PCX
View VHT's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $18,155M
Expense Ratio: 0.09% (Very Low)
Volume: 143.3K (Moderate)
Issuer: Vanguard
Holdings: 419
Inception: 2004-01-26 (21 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

The iShares U.S. Healthcare ETF offers exposure to U.S. health care companies, aligning closely with VHT’s focus on health care and biotech equities.

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 99%

R-squared: 98%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 7
  • IYH in VHT's comparables: Yes
  • VHT in IYH's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 21.73 vs 22.00

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • IYH Beta: 0.71 (Low)
  • VHT Beta: 0.73 (Low)
  • IYH 200-day Volatility: 10.38%
  • VHT 200-day Volatility: 10.58%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • IYH Price vs 200-day MA: 100%
  • VHT Price vs 200-day MA: 100%

Performance Comparison:

Period IYH VHT
Year_1 15% 15%
Year_3 5% 4%
Year_5 12% 11%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
B+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • IYH Dividend Yield: 3%
  • VHT Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
22.00
Annual Dividend Rate
1.28%
Beta
0.73
50-Day Moving Average
$264.61
Price vs. 50-Day MA
2.28%
200-Day Moving Average
$271.01
Price vs. 200-Day MA
-0.14%
1 Year Fund Flow
-$853M (-5% of AUM)
3 Year Fund Flow
$751M (4% of AUM)
5 Year Fund Flow
$3,074M (17% of AUM)
% in Top 10 Holdings
48%
% in Top 15 Holdings
59%
% in Top 50 Holdings
86%
ESG Score
6.5900
ESG Peer %
54.32
ESG Global %
52.52
Carbon Intensity
15
ESG Exclusion %
0.02
Sustainable Impact %
10.85
Toggle between similar ETFs and stocks for comparison.

Loading comparable ETFs ...

Vanguard Health Care Index Fund ETF Shares

VHT - PCX
A+
$270.64 -1.73 (-0.63%)
Health & Biotech Equities
Equity
AUM: $18,155M
Expense Ratio: 0.09% (Very Low)
Volume: 143.3K (Moderate)
Issuer: Vanguard
Holdings: 419
Inception: 2004-01-26 (21 years)
Neutral Momentum
Large AUM
Very Low Concentration
Low Volatility